LGALS9 and neoplasm: CLEC7A, which is highly expressed in M2-like tumor-associated macrophages, is linked to galectin 9, thus leading to tolerogenic macrophage programming and adaptive immunosuppression that contribute to tumor exacerbation (Daley et al., 2017; Zhou et al., 2021a).